ER

Ellen Rothenberg

Scientific Advisor at Century Therapeutics

Dr. Ellen Rothenberg studies the molecular mechanisms that are responsible for developmental lineage choice as hematopoietic stem cells differentiate into T lymphocytes. Her work is focused on identifying the transcription factors and signaling events that induce T-lineage gene expression in an uncommitted precursor and determining how they work to force the cell to relinquish other developmental options.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Century Therapeutics

1 followers

Century Therapeutics is harnessing the power of stem cells to develop curative cell therapy products for cancer.


Industries

Employees

51-200

Links